156 related articles for article (PubMed ID: 28835099)
1. Glutathione-Sensitive Hyaluronic Acid-Mercaptopurine Prodrug Linked via Carbonyl Vinyl Sulfide: A Robust and CD44-Targeted Nanomedicine for Leukemia.
Qiu J; Cheng R; Zhang J; Sun H; Deng C; Meng F; Zhong Z
Biomacromolecules; 2017 Oct; 18(10):3207-3214. PubMed ID: 28835099
[TBL] [Abstract][Full Text] [Related]
2. Application and Analysis of 6-Mercaptopurine Nanomedicine in the Treatment of Leukemia.
Lu X; Xie Y; Wang F
J Nanosci Nanotechnol; 2021 Feb; 21(2):1001-1007. PubMed ID: 33183436
[TBL] [Abstract][Full Text] [Related]
3. Glutathione-Sensitive Hyaluronic Acid-SS-Mertansine Prodrug with a High Drug Content: Facile Synthesis and Targeted Breast Tumor Therapy.
Zhong P; Zhang J; Deng C; Cheng R; Meng F; Zhong Z
Biomacromolecules; 2016 Nov; 17(11):3602-3608. PubMed ID: 27723970
[TBL] [Abstract][Full Text] [Related]
4. Hyaluronic acid-shelled acid-activatable paclitaxel prodrug micelles effectively target and treat CD44-overexpressing human breast tumor xenografts in vivo.
Zhong Y; Goltsche K; Cheng L; Xie F; Meng F; Deng C; Zhong Z; Haag R
Biomaterials; 2016 Apr; 84():250-261. PubMed ID: 26851390
[TBL] [Abstract][Full Text] [Related]
5. Reversibly crosslinked hyaluronic acid nanoparticles for active targeting and intelligent delivery of doxorubicin to drug resistant CD44+ human breast tumor xenografts.
Zhong Y; Zhang J; Cheng R; Deng C; Meng F; Xie F; Zhong Z
J Control Release; 2015 May; 205():144-54. PubMed ID: 25596560
[TBL] [Abstract][Full Text] [Related]
6. Redox-Responsive and Dual-Targeting Hyaluronic Acid-Methotrexate Prodrug Self-Assembling Nanoparticles for Enhancing Intracellular Drug Self-Delivery.
Zhang Y; Li Y; Tian H; Zhu Q; Wang F; Fan Z; Zhou S; Wang X; Xie L; Hou Z
Mol Pharm; 2019 Jul; 16(7):3133-3144. PubMed ID: 31198046
[TBL] [Abstract][Full Text] [Related]
7. Folate Receptor-Targeted and GSH-Responsive Carboxymethyl Chitosan Nanoparticles Containing Covalently Entrapped 6-Mercaptopurine for Enhanced Intracellular Drug Delivery in Leukemia.
Wei X; Liao J; Davoudi Z; Zheng H; Chen J; Li D; Xiong X; Yin Y; Yu X; Xiong J; Wang Q
Mar Drugs; 2018 Nov; 16(11):. PubMed ID: 30413077
[TBL] [Abstract][Full Text] [Related]
8. Effects of vehicles and prodrug properties and their interactions on the delivery of 6-mercaptopurine through skin: bisacyloxymethyl-6-mercaptopurine prodrugs.
Waranis RP; Sloan KB
J Pharm Sci; 1987 Aug; 76(8):587-95. PubMed ID: 11002816
[TBL] [Abstract][Full Text] [Related]
9. Tumor targeting profiling of hyaluronan-coated lipid based-nanoparticles.
Mizrahy S; Goldsmith M; Leviatan-Ben-Arye S; Kisin-Finfer E; Redy O; Srinivasan S; Shabat D; Godin B; Peer D
Nanoscale; 2014 Apr; 6(7):3742-52. PubMed ID: 24569711
[TBL] [Abstract][Full Text] [Related]
10. Facile fabrication of robust, hyaluronic acid-surfaced and disulfide-crosslinked PLGA nanoparticles for tumor-targeted and reduction-triggered release of docetaxel.
Wang X; Cheng R; Zhong Z
Acta Biomater; 2021 Apr; 125():280-289. PubMed ID: 33677162
[TBL] [Abstract][Full Text] [Related]
11. Hyaluronic acid shell and disulfide-crosslinked core micelles for in vivo targeted delivery of bortezomib for the treatment of multiple myeloma.
Gu Z; Wang X; Cheng R; Cheng L; Zhong Z
Acta Biomater; 2018 Oct; 80():288-295. PubMed ID: 30240956
[TBL] [Abstract][Full Text] [Related]
12. Preparation, Characterization, Pharmacokinetic, and Therapeutic Potential of Novel 6-Mercaptopurine-Loaded Oral Nanomedicines for Acute Lymphoblastic Leukemia.
Zou Y; Mei D; Yuan J; Han J; Xu J; Sun N; He H; Yang C; Zhao L
Int J Nanomedicine; 2021; 16():1127-1141. PubMed ID: 33603372
[TBL] [Abstract][Full Text] [Related]
13. Hyaluronic Acid-Shelled Disulfide-Cross-Linked Nanopolymersomes for Ultrahigh-Efficiency Reactive Encapsulation and CD44-Targeted Delivery of Mertansine Toxin.
Zhang Y; Wu K; Sun H; Zhang J; Yuan J; Zhong Z
ACS Appl Mater Interfaces; 2018 Jan; 10(2):1597-1604. PubMed ID: 29272095
[TBL] [Abstract][Full Text] [Related]
14. Novel Curcumin Liposome Modified with Hyaluronan Targeting CD44 Plays an Anti-Leukemic Role in Acute Myeloid Leukemia in Vitro and in Vivo.
Sun D; Zhou JK; Zhao L; Zheng ZY; Li J; Pu W; Liu S; Liu XS; Liu SJ; Zheng Y; Zhao Y; Peng Y
ACS Appl Mater Interfaces; 2017 May; 9(20):16857-16868. PubMed ID: 28489348
[TBL] [Abstract][Full Text] [Related]
15. CD44-Targeted Multifunctional Nanomedicines Based on a Single-Component Hyaluronic Acid Conjugate with All-Natural Precursors: Construction and Treatment of Metastatic Breast Tumors
Fang H; Zhao X; Gu X; Sun H; Cheng R; Zhong Z; Deng C
Biomacromolecules; 2020 Jan; 21(1):104-113. PubMed ID: 31532629
[TBL] [Abstract][Full Text] [Related]
16. Effects of vehicles and prodrug properties and their interactions on the delivery of 6-mercaptopurine through skin: S6-acyloxymethyl-6-mercaptopurine prodrugs.
Waranis RP; Sloan KB
J Pharm Sci; 1988 Mar; 77(3):210-5. PubMed ID: 3373424
[TBL] [Abstract][Full Text] [Related]
17. High-entrapment liposomes for 6-Mercaptopurine--a prodrug approach.
Taneja D; Namdeo A; Mishra PR; Khopade AJ; Jain NK
Drug Dev Ind Pharm; 2000 Dec; 26(12):1315-9. PubMed ID: 11147134
[TBL] [Abstract][Full Text] [Related]
18. Targeted inhibition of human hematological cancers in vivo by doxorubicin encapsulated in smart lipoic acid-crosslinked hyaluronic acid nanoparticles.
Zhong Y; Meng F; Deng C; Mao X; Zhong Z
Drug Deliv; 2017 Nov; 24(1):1482-1490. PubMed ID: 28958164
[TBL] [Abstract][Full Text] [Related]
19. Hyaluronic acid oligosaccharide modified redox-responsive mesoporous silica nanoparticles for targeted drug delivery.
Zhao Q; Geng H; Wang Y; Gao Y; Huang J; Wang Y; Zhang J; Wang S
ACS Appl Mater Interfaces; 2014 Nov; 6(22):20290-9. PubMed ID: 25311422
[TBL] [Abstract][Full Text] [Related]
20. Preparation, characterization and in vitro release study of a glutathione-dependent polymeric prodrug Cis-3-(9H-purin-6-ylthio)-acrylic acid-graft-carboxymethyl chitosan.
Gong XY; Yin YH; Huang ZJ; Lu B; Xu PH; Zheng H; Xiong FL; Xu HX; Xiong X; Gu XB
Int J Pharm; 2012 Oct; 436(1-2):240-7. PubMed ID: 22750430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
